Diagnostic Accuracy Studies: Design, Measures, and Reporting

Diagnostic accuracy studies evaluate how well a test identifies a target condition compared with a reference standard. These studies answer a practical question: when a farmer, clinician, or researcher applies a diagnostic test to animals or samples, how often does the test result match the true disease status? The answer depends on study design, the choice of accuracy measures, and the completeness of reporting. This article explains the core design options, the standard metrics used to express test performance, and the reporting framework that allows others to judge whether study findings are trustworthy and applicable to their own setting.

Diagnostic accuracy research sits within the broader category of observational study designs, which also include cross-sectional, case-control, and cohort approaches. Each design has strengths and weaknesses, and understanding these limitations is necessary to arrive at correct study conclusions. Diagnostic study designs specifically evaluate the accuracy of diagnostic procedures and tests as compared with other diagnostic measures. These include diagnostic accuracy designs, diagnostic cohort designs, and diagnostic randomized controlled trials. The medical community often assumes that the tests used to diagnose various diseases are accurate, safe, and effective, yet the study designs traditionally used to determine whether a diagnostic test is indeed accurate, safe, and effective are often at a higher risk of bias and of lower methodological quality than those evaluating therapeutic interventions.

For animal farming contexts, diagnostic accuracy studies matter because testing decisions carry economic and welfare consequences. A test with poor sensitivity may miss infected animals and allow disease spread within a herd. A test with poor specificity may generate false positives that lead to unnecessary culling, treatment, or trade restrictions. Understanding how accuracy measures are derived and how study design affects those measures helps producers and veterinarians interpret test results and choose appropriate testing strategies.

What a Diagnostic Accuracy Study Measures

A diagnostic accuracy study compares the results of an index test with the results of a reference standard applied to the same subjects. The index test is the test being evaluated. The reference standard is the best available method for determining the true presence or absence of the target condition. The comparison produces a two-by-two table that classifies each subject as true positive, false positive, true negative, or false negative relative to the reference standard.

The core accuracy measures derived from this table are sensitivity, specificity, predictive values, and likelihood ratios. Sensitivity is the proportion of subjects with the target condition who test positive. Specificity is the proportion of subjects without the target condition who test negative. Positive predictive value is the proportion of subjects who test positive who actually have the condition. Negative predictive value is the proportion of subjects who test negative who actually do not have the condition. Likelihood ratios express how much a test result changes the odds of disease.

To make clinical decisions and guide patient care, providers must understand the likelihood that a patient has a disease, integrating pretest probability with diagnostic test results. Diagnostic tools are routinely utilized in healthcare settings to determine treatment methods, yet many of these tools are subject to error. The same principle applies in veterinary and agricultural settings, where test results inform treatment, isolation, culling, and movement decisions.

The area under the receiver operating characteristic curve, commonly abbreviated as AUC, provides an overall index of accuracy across all possible test thresholds. The AUC summarizes the trade-off between sensitivity and specificity as the test threshold changes. A test with an AUC near 1.0 has excellent discrimination, while a test with an AUC near 0.5 performs no better than chance.

Study Designs for Diagnostic Accuracy

Several designs can be used to study diagnostic tests, including diagnostic accuracy cross-sectional studies, diagnostic accuracy case-control studies, and diagnostic accuracy comparative studies. The choice of design affects the risk of bias and the generalizability of findings.

Cross-Sectional Diagnostic Accuracy Studies

In a cross-sectional diagnostic accuracy study, the index test and reference standard are applied to a single group of subjects recruited from a defined population. This design most closely mirrors clinical or field practice because subjects represent the spectrum of disease severity and comorbidity seen in the target population. The Dan-NICAD 2 study provides an example of a prospective, multicenter, cross-sectional design. That study enrolled approximately 2,000 patients with low to intermediate pretest probability of coronary artery disease and compared multiple noninvasive tests against invasive coronary angiography with fractional flow reserve as the reference standard. The design allowed direct comparison of several index tests in the same population.

For animal health applications, a cross-sectional design might involve sampling a representative group of animals from a herd or region, applying the index test to all samples, and confirming results with the reference standard. This approach yields estimates of sensitivity and specificity that reflect real-world conditions, including the mix of early and late disease, mild and severe cases, and animals with concurrent conditions.

Case-Control Diagnostic Accuracy Studies

A case-control diagnostic accuracy study selects subjects based on known disease status, typically including a group known to have the condition and a group known to be free of the condition. This design is often easier and less expensive to conduct because it does not require screening a large population to find enough cases. However, case-control designs can overestimate accuracy because they exclude the ambiguous and intermediate cases that present diagnostic challenges in practice.

The choice of study design can substantially influence accuracy estimates. A meta-analysis examining the effect of study design biases on the diagnostic accuracy of magnetic resonance imaging for detecting silicone breast implant ruptures found that studies evaluating symptomatic subjects had 14-fold higher diagnostic accuracy estimates compared with studies using an asymptomatic sample. The relative diagnostic odds ratio was 13.8 with a 95 percent confidence interval of 1.83 to 104.6. Studies using a screening sample showed a 2-fold higher estimate compared with asymptomatic samples. This example demonstrates that the spectrum of subjects included in a study can dramatically change the apparent performance of a test.

In animal health, a case-control design might compare samples from animals with confirmed disease against samples from healthy animals. This approach can provide an initial assessment of whether a test can distinguish clearly affected from clearly unaffected animals. However, the results may not reflect how the test performs in a herd where most animals have mild or subclinical disease and where other conditions produce similar signs.

Comparative Diagnostic Accuracy Studies

Comparative diagnostic accuracy studies evaluate two or more index tests in the same population. These studies can use either a paired design, where all subjects receive all tests, or an unpaired design, where different subjects receive different tests. The paired design is generally more efficient because each subject serves as its own control, but it requires careful attention to the order of testing and the potential for one test to influence the interpretation of another.

Comparative designs are particularly relevant when deciding whether a new test can replace an existing test. The choice of study design for diagnostic accuracy studies has been examined in various clinical contexts, including the use of Borrelia-specific IgG and IgM antibodies for the diagnosis of Lyme borreliosis. The design choice affects whether the comparison reflects real-world testing conditions and whether the results can guide clinical decisions.

Diagnostic Randomized Controlled Trials

Diagnostic randomized controlled trials assign subjects to receive different diagnostic strategies and compare patient outcomes. These trials represent a higher level of evidence than observational diagnostic accuracy studies because randomization helps balance known and unknown confounders between groups. However, diagnostic randomized trials are more complex and expensive to conduct, and they may not be necessary when the question is simply whether a test accurately identifies a condition.

Clinicians, researchers, and policy-makers may wish to consider moving toward higher quality study designs when studying new diagnostic modalities prior to their implementation in routine practice, and diagnostic randomized trials are one such alternative. For animal health applications, a diagnostic randomized trial might compare a testing strategy that uses a new rapid test against a strategy that uses laboratory confirmation, with outcomes measured in terms of disease detection, treatment decisions, or economic impact.

Reference Standards and Their Limitations

The reference standard is the foundation of any diagnostic accuracy study. If the reference standard is imperfect, the accuracy of the index test will be underestimated or overestimated depending on the nature of the error. Multireader diagnostic accuracy imaging studies need a reference standard and sampling from two populations, namely the reader and patient populations. One common problem is the use of imperfect reference standards, often correlated with the test or tests being evaluated.

In animal health, reference standards vary by condition. For bacterial diseases, bacterial culture or polymerase chain reaction may serve as the reference standard. For parasitic infections, fecal egg counts or necropsy findings may be used. For conditions diagnosed by imaging, expert interpretation of images may be the reference standard. Each reference standard has its own limitations, and these limitations should be acknowledged in the study report.

When the reference standard is imperfect, the study should describe how reference standard errors were handled. Options include using a composite reference standard that combines multiple tests, applying a latent class analysis that models the true disease status, or restricting the study to subjects where the reference standard is most reliable. The choice of approach should be justified in the study protocol.

Sample Size Considerations

Sample size calculation is a critical step in planning a diagnostic accuracy study. The sample size must be large enough to estimate sensitivity and specificity with adequate precision or to detect a meaningful difference between two tests. The formulae for sample size calculations in diagnostic test accuracy studies depend on the accuracy index of interest, the desired confidence interval width, and the expected effect size.

A review of sample size estimation in diagnostic test studies of biomedical informatics provided a conceptual framework for these calculations under various conditions and test outcomes. The formulae for sample size calculations for estimation of adequate sensitivity and specificity, likelihood ratio, and AUC as an overall index of accuracy have been presented for desired confidence intervals. The review also covered sample size calculations for testing in single modality and for comparing two diagnostic tasks. The results show how sample size varies with the accuracy index and effect size of interest. This information helps clinicians choose an adequate sample size based on statistical principles to guarantee the reliability of the study.

For a study estimating sensitivity, the sample size depends on the expected sensitivity, the desired precision of the estimate, and the confidence level. For a study comparing two tests, the sample size depends on the expected difference in accuracy, the power to detect that difference, and the correlation between test results in a paired design.

Blinded Sample Size Re-Estimation

The sample size calculation in a confirmatory diagnostic accuracy study is performed for co-primary endpoints because sensitivity and specificity are considered simultaneously. The initial sample size calculation in an unpaired and paired diagnostic study is based on assumptions about the prevalence of the disease and, in the paired design, the proportion of discordant test results between the experimental and the comparator test. The choice of the power for the individual endpoints impacts the sample size and overall power. Uncertain assumptions about the nuisance parameters can additionally affect the sample size.

An optimal sample size calculation considering co-primary endpoints can avoid an overpowered study in the unpaired and paired design. To adjust assumptions about the nuisance parameters during the study period, a blinded adaptive design for sample size re-estimation has been introduced for the unpaired and the paired study design. Due to blinding, the adaptive design does not inflate type I error rates. The adaptive design reaches the target power and re-estimates nuisance parameters without any relevant bias. Compared to the existing approach, the proposed methods lead to a smaller sample size. The application of the optimal sample size calculation and a blinded adaptive design in a confirmatory diagnostic accuracy study is recommended because these approaches compensate for inefficiencies in the sample size calculation and support reaching the study aim.

For animal health researchers, this means that sample size should not be treated as a one-time calculation performed at the start of the study. If key assumptions are uncertain, a blinded re-estimation during the study can help ensure the study has adequate power without enrolling more animals than necessary.

Accuracy Measures in Practice

The choice of accuracy measures depends on the purpose of the test and the consequences of test errors. Sensitivity and specificity describe the intrinsic properties of a test, while predictive values describe how the test performs in a specific population with a given prevalence of disease.

Sensitivity and Specificity

Sensitivity answers the question: among animals that truly have the condition, what proportion test positive? A highly sensitive test is valuable for ruling out disease because a negative result provides strong evidence that the condition is absent. Specificity answers the question: among animals that truly do not have the condition, what proportion test negative? A highly specific test is valuable for ruling in disease because a positive result provides strong evidence that the condition is present.

The trade-off between sensitivity and specificity is often managed by choosing a test threshold. Lowering the threshold for a positive result increases sensitivity but decreases specificity. Raising the threshold increases specificity but decreases sensitivity. The AUC captures this trade-off across all possible thresholds.

A prospective diagnostic accuracy study of automated real-time detection of lung sliding using artificial intelligence illustrates how sensitivity and specificity are reported in practice. The study evaluated an AI-assisted lung ultrasound system for detecting the absence of lung sliding in patients with suspected pneumothorax. The AI system had a sensitivity of 0.921 with a 95 percent confidence interval of 0.792 to 0.973, a specificity of 0.802 with a 95 percent confidence interval of 0.735 to 0.856, and an AUC of 0.885 with a 95 percent confidence interval of 0.828 to 0.956. The study demonstrated high sensitivity and moderate specificity for identifying the absence of lung sliding.

Predictive Values

Predictive values depend on the prevalence of the condition in the tested population. Positive predictive value increases as prevalence increases, while negative predictive value decreases. This dependence means that predictive values from one study cannot be directly applied to a population with a different prevalence.

For animal health decisions, predictive values are often more useful than sensitivity and specificity because they directly answer the question: given a positive test result, how likely is the animal to actually have the condition? However, predictive values must be interpreted in the context of the specific herd or population being tested.

Likelihood Ratios

Likelihood ratios combine sensitivity and specificity into a single measure that can be used to update the probability of disease. The positive likelihood ratio is the probability of a positive test result in diseased animals divided by the probability of a positive test result in nondiseased animals. The negative likelihood ratio is the probability of a negative test result in diseased animals divided by the probability of a negative test result in nondiseased animals.

A multicenter prospective observational study of lung ultrasound scores for predicting bronchopulmonary dysplasia in infants reported a cut-off of 8 points in the anterolateral lung ultrasound score at the 7th day of life that provided a sensitivity of 70 percent, a specificity of 79 percent, a positive likelihood ratio of 3.3, and a negative likelihood ratio of 0.38. These values illustrate how likelihood ratios convey the clinical value of a test result.

Area Under the Receiver Operating Characteristic Curve

The AUC provides a single number that summarizes the discriminative ability of a test across all thresholds. An AUC of 0.5 indicates no discriminative ability, while an AUC of 1.0 indicates perfect discrimination. In practice, AUC values above 0.7 are often considered acceptable, values above 0.8 are considered good, and values above 0.9 are considered excellent, although these thresholds are conventions instead of absolute rules.

A retrospective observational study of electrophysiological markers in hypertrophic cardiomyopathy used ROC curve analysis to evaluate the predictive value of the Index of Cardiac Electrophysiological Balance and its corrected variant for ventricular arrhythmias. The study found that the highest area under the curve was for the Base plus ICEB Model with an AUC of 0.79. This example shows how AUC is used to compare the predictive power of different models or markers.

At a Glance

Reporting Standards for Diagnostic Accuracy Studies

Diagnostic accuracy studies are, like other clinical studies, at risk of bias due to shortcomings in design and conduct, and the results of a diagnostic accuracy study may not apply to other patient groups and settings. Readers of study reports need to be informed about study design and conduct, in sufficient detail to judge the trustworthiness and applicability of the study findings. The STARD statement, which stands for Standards for Reporting of Diagnostic Accuracy Studies, was developed to improve the completeness and transparency of reports of diagnostic accuracy studies.

STARD contains a list of essential items that can be used as a checklist by authors, reviewers, and other readers to ensure that a report of a diagnostic accuracy study contains the necessary information. STARD was recently updated, and all updated STARD materials, including the checklist, are available through the EQUATOR Network. The STARD 2015 explanation and elaboration document clarifies the rationale for each of the 30 items on the STARD 2015 checklist and describes what is expected from authors in developing sufficiently informative study reports.

The EQUATOR Network serves as a central repository for reporting guidelines across study types. Researchers planning a diagnostic accuracy study should consult the EQUATOR Network to identify the appropriate reporting guideline and to access the latest versions of checklists and explanation documents.

Key Items in the STARD Checklist

The STARD 2015 checklist covers the title and abstract, introduction, methods, results, and discussion sections of a study report. Key items include:

• Identification of the study as a diagnostic accuracy study in the title or abstract
• Structured summary of study design, methods, results, and conclusions
• Scientific and clinical background, including the intended use and clinical role of the index test
• Study objectives and hypotheses
• Study design and whether the study was prospective or retrospective
• Eligibility criteria and where and when participants were recruited
• Whether participants formed a consecutive, random, or convenience series
• Index test description, including how and when the test was performed
• Reference standard description, including rationale for choosing it
• Whether the index test and reference standard were blinded to each other
• Methods for calculating or comparing measures of diagnostic accuracy
• Methods for estimating sample size
• Flow of participants through the study
• Baseline demographic and clinical characteristics of participants
• Time interval between index test and reference standard
• Cross-tabulation of index test results by reference standard results
• Estimates of diagnostic accuracy and their precision
• Adverse events from performing the index test or reference standard
• Study limitations and sources of potential bias
• Implications for practice and future research

Using the STARD Checklist in Animal Health Research

For animal health researchers, the STARD checklist provides a framework for planning and reporting diagnostic accuracy studies. The checklist can be used during the design phase to ensure that all essential elements are addressed before data collection begins. It can also be used during manuscript preparation to verify that the report contains all necessary information.

The checklist is particularly valuable for ensuring that the study population is described in sufficient detail. Readers need to know the species, breed, age range, production system, and disease prevalence in the study population to judge whether the results apply to their own setting. The checklist also requires authors to describe the reference standard and its rationale, which helps readers assess whether the reference standard is appropriate for the target condition.

Practical Steps for Planning a Diagnostic Accuracy Study

Planning a diagnostic accuracy study requires attention to several key decisions. The following steps provide a framework for developing a study protocol.

Step 1: Define the Clinical Question and Target Condition

The first step is to define the clinical question precisely. What condition is the test intended to detect? What is the intended use of the test? Is the test intended to screen asymptomatic animals, confirm suspected cases, or monitor response to treatment? The answers to these questions determine the appropriate study design and the relevant accuracy measures.

The target condition should be defined with clear diagnostic criteria. For infectious diseases, the target condition might be defined by detection of the pathogen, by serological evidence of exposure, or by clinical signs. The definition should be specified in the protocol before data collection begins.

Step 2: Select the Study Design

The study design should match the clinical question and the practical constraints of the setting. A cross-sectional design is appropriate when the goal is to estimate test accuracy in a population that reflects real-world conditions. A case-control design may be appropriate for initial test validation when the condition is rare or when the reference standard is expensive. A comparative design is appropriate when the goal is to compare two or more tests.

The choice of design should consider the risk of bias associated with each approach. Case-control designs are particularly susceptible to spectrum bias because they exclude intermediate cases. Cross-sectional designs are less susceptible to this bias but require larger sample sizes for rare conditions.

Step 3: Define the Reference Standard

The reference standard should be the best available method for determining the true presence or absence of the target condition. The reference standard should be applied to all subjects, and the personnel performing the reference standard should be blinded to the index test results.

When no perfect reference standard exists, the protocol should describe how imperfect reference standard error will be handled. Options include using a composite reference standard, applying latent class analysis, or restricting the study to subjects where the reference standard is most reliable.

Step 4: Calculate the Sample Size

Sample size should be calculated based on the primary accuracy measure and the desired precision or power. For studies estimating sensitivity or specificity, the sample size depends on the expected value of the measure, the desired confidence interval width, and the confidence level. For comparative studies, the sample size depends on the expected difference between tests, the power to detect that difference, and the correlation between test results.

The sample size calculation should be documented in the protocol, including all assumptions. If key assumptions are uncertain, a blinded sample size re-estimation during the study can help ensure adequate power.

Step 5: Plan Data Collection and Blinding

Data collection procedures should be specified in advance. The index test and reference standard should be performed independently, with personnel blinded to the results of the other test. Blinding prevents the interpretation of one test from being influenced by knowledge of the other test result.

For studies involving multiple readers or interpreters, the protocol should specify how many readers will interpret the results, how disagreements will be resolved, and how reader variability will be analyzed. Multireader multicase studies are quite challenging because they need a reference standard and sampling from two populations, namely the reader and patient populations. These studies are quite expensive to conduct, requiring a good deal of readers' time for image interpretation.

Step 6: Plan the Statistical Analysis

The statistical analysis plan should specify the primary and secondary accuracy measures, the methods for calculating confidence intervals, and the methods for comparing tests if applicable. The plan should also specify how missing data will be handled and whether any subgroup analyses are planned.

For studies evaluating tests with continuous results, the analysis plan should specify how the test threshold will be selected and whether the AUC will be reported. The plan should also address whether the study is powered for co-primary endpoints of sensitivity and specificity.

Step 7: Register the Study and Prepare the Report

Study registration is recommended for diagnostic accuracy studies, particularly for confirmatory studies. Registration helps prevent selective reporting and allows others to identify ongoing or completed studies.

The study report should follow the STARD checklist to ensure completeness and transparency. The report should describe the study design, the study population, the index test, the reference standard, the sample size calculation, and the statistical methods. The results should include the flow of participants, the cross-tabulation of test results, and the estimates of accuracy with confidence intervals.

Records and Measurements

Accurate record keeping is essential for diagnostic accuracy studies. The following records should be maintained throughout the study.

Subject Recruitment Log

The recruitment log should document every subject considered for the study, including those who were eligible but not enrolled and those who were enrolled but did not complete the study. The log should record the date of recruitment, the reason for exclusion if applicable, and the unique identifier for each enrolled subject.

Test Result Records

The index test results and reference standard results should be recorded independently, with the personnel performing each test blinded to the other result. The records should include the date and time of testing, the person performing the test, and any technical issues that arose during testing.

Quality Control Records

Quality control records should document the performance of the index test and reference standard over time. For laboratory tests, this includes records of calibration, control samples, and reagent lots. For imaging tests, this includes records of equipment settings and image quality.

Adverse Event Records

Any adverse events associated with performing the index test or reference standard should be recorded. In animal health studies, adverse events might include complications from sample collection, reactions to test agents, or welfare concerns related to handling or restraint.

Common Failure Patterns in Diagnostic Accuracy Studies

Several recurring problems can compromise the validity of diagnostic accuracy studies. Recognizing these failure patterns helps researchers design better studies and helps readers interpret published reports.

Spectrum Bias

Spectrum bias occurs when the study population does not reflect the full spectrum of disease seen in the target population. Case-control designs are particularly susceptible to this bias because they include only clearly affected and clearly unaffected subjects. The result is often an overestimate of test accuracy.

The meta-analysis of magnetic resonance imaging for detecting silicone breast implant ruptures provides a striking example of spectrum bias. Studies evaluating symptomatic subjects had 14-fold higher diagnostic accuracy estimates compared with studies using an asymptomatic sample. Many of the published studies using magnetic resonance imaging or ultrasound to detect silicone breast implant rupture were flawed with methodologic biases, and these methodologic shortcomings may result in overestimated diagnostic accuracy measures.

Verification Bias

Verification bias occurs when not all subjects receive the reference standard. This bias often arises when the reference standard is invasive, expensive, or risky, leading researchers to apply it selectively. For example, if only subjects with positive index test results receive the reference standard, the study will overestimate sensitivity and underestimate specificity.

Incorporation Bias

Incorporation bias occurs when the index test is part of the reference standard. This bias inflates the apparent accuracy of the index test because the test is being compared against a standard that includes the test itself.

Imperfect Reference Standard Bias

Imperfect reference standard bias occurs when the reference standard misclassifies some subjects. This bias can either overestimate or underestimate test accuracy depending on the nature of the reference standard error. Multireader diagnostic accuracy imaging studies commonly face the problem of imperfect reference standards, often correlated with the test or tests being evaluated.

Handling of Indeterminate Results

Indeterminate or uninterpretable test results are a common challenge in diagnostic accuracy studies. If these results are excluded from the analysis, the study may overestimate test accuracy because indeterminate results are more likely to occur in difficult cases. The STARD checklist requires authors to report how indeterminate results were handled.

Reader Variability

For tests that require subjective interpretation, reader variability can affect accuracy estimates. Multireader multicase studies require sampling from both the reader and patient populations, and the analysis must account for variability from both sources. Oversimplification of the multidimensional data is a common issue in these studies.

Limitations of Diagnostic Accuracy Studies

Diagnostic accuracy studies have inherent limitations that should be acknowledged in study reports and considered when interpreting results.

Applicability to Other Settings

The results of a diagnostic accuracy study may not apply to other patient groups and settings. Differences in disease prevalence, disease severity, and population characteristics can affect predictive values and may also affect sensitivity and specificity. The STARD checklist requires authors to describe the study population in sufficient detail for readers to judge applicability.

Focus on Accuracy instead of Outcomes

Diagnostic accuracy studies measure how well a test identifies a condition, but they do not measure whether using the test improves health outcomes. A test can be highly accurate without improving outcomes if the condition cannot be treated effectively or if the test does not change clinical decisions. Diagnostic randomized trials are needed to evaluate the impact of testing on outcomes.

Dependence on the Reference Standard

The validity of a diagnostic accuracy study depends on the quality of the reference standard. If the reference standard is imperfect, the accuracy estimates will be biased. The direction and magnitude of the bias depend on the nature of the reference standard error and its correlation with the index test.

Limited Information on Test Utility

Accuracy measures describe test performance but do not capture all aspects of test utility. Factors such as cost, speed, ease of use, and animal welfare implications are not reflected in sensitivity and specificity. These factors should be considered alongside accuracy when deciding whether to adopt a test.

Welfare and Safety Context

Diagnostic accuracy studies involving animals must consider the welfare of the animals being tested. The following considerations apply to study design and conduct.

Sample Collection Procedures

Sample collection procedures should minimize pain, distress, and harm to animals. Blood collection, tissue biopsy, and other invasive procedures should be performed by trained personnel using appropriate restraint and anesthesia. The study protocol should specify the maximum number of samples per animal and the intervals between sampling events.

Use of the Reference Standard

The reference standard may involve procedures that are more invasive or more stressful than the index test. For example, a reference standard might require necropsy, surgical biopsy, or prolonged handling. The study design should balance the need for accurate reference standard results against the welfare of the animals.

Ethical Review

Studies involving animals should be reviewed by an institutional animal care and use committee or equivalent ethics body before data collection begins. The review should address the scientific justification for the study, the welfare implications of the procedures, and the plans for minimizing harm.

Regulatory Compliance

Diagnostic accuracy studies may be subject to regulatory requirements depending on the jurisdiction and the nature of the test being evaluated. Researchers should identify applicable regulations and obtain necessary approvals before starting the study.

Professional Escalation Criteria

Researchers and practitioners should recognize when a diagnostic accuracy study requires additional expertise or when results should be interpreted with caution.

When to Consult a Biostatistician

A biostatistician should be consulted during the design phase to ensure that the sample size calculation is appropriate and that the statistical analysis plan is sound. Consultation is particularly important for comparative studies, studies with co-primary endpoints, and studies involving multireader data.

When to Seek Regulatory Guidance

If the diagnostic test is intended for commercial use or if the study results will be used to support regulatory approval, regulatory guidance should be sought early in the planning process. The requirements for test validation may differ from the requirements for a research study.

When to Interpret Results with Caution

Results should be interpreted with caution when the study has methodologic limitations, when the study population differs substantially from the target population, or when the reference standard is imperfect. The STARD checklist can help readers identify these limitations.

When to Consider a Diagnostic Randomized Trial

If the question is not simply whether a test is accurate but whether using the test improves outcomes, a diagnostic randomized trial may be appropriate. These trials are more complex and expensive than diagnostic accuracy studies but provide higher quality evidence for clinical and policy decisions.

Frequently Asked Questions

What is the difference between sensitivity and specificity?

Sensitivity is the proportion of animals with the target condition that test positive. Specificity is the proportion of animals without the target condition that test negative. A highly sensitive test is useful for ruling out disease because a negative result strongly suggests the condition is absent. A highly specific test is useful for ruling in disease because a positive result strongly suggests the condition is present.

Why do predictive values change with disease prevalence?

Predictive values depend on the prevalence of the condition in the tested population. Positive predictive value increases as prevalence increases because a larger proportion of positive results come from truly affected animals. Negative predictive value decreases as prevalence increases because a larger proportion of negative results come from truly affected animals that were missed by the test.

What is the difference between a cross-sectional and a case-control diagnostic accuracy study?

A cross-sectional diagnostic accuracy study applies the index test and reference standard to a sample of subjects from the target population. A case-control study selects subjects based on known disease status, typically including a group with the condition and a group without it. Cross-sectional designs better reflect real-world conditions but require larger samples for rare conditions. Case-control designs are more efficient but may overestimate accuracy due to spectrum bias.

What is the STARD checklist and why is it important?

The STARD checklist is a list of essential items that should be included in reports of diagnostic accuracy studies. It was developed to improve the completeness and transparency of study reports. The checklist helps authors, reviewers, and readers ensure that a report contains the necessary information to judge the trustworthiness and applicability of the study findings.

How is sample size determined for a diagnostic accuracy study?

Sample size depends on the primary accuracy measure, the expected value of that measure, the desired precision or power, and the confidence level. For studies estimating sensitivity or specificity, the sample size is calculated to achieve a desired confidence interval width. For comparative studies, the sample size is calculated to detect a meaningful difference between tests with adequate power.

What is the area under the receiver operating characteristic curve?

The area under the receiver operating characteristic curve, abbreviated as AUC, summarizes the discriminative ability of a test across all possible thresholds. An AUC of 0.5 indicates no discriminative ability, while an AUC of 1.0 indicates perfect discrimination. The AUC is useful for comparing the overall accuracy of different tests or models.

What is spectrum bias and how does it affect diagnostic accuracy studies?

Spectrum bias occurs when the study population does not reflect the full spectrum of disease seen in the target population. Case-control designs are particularly susceptible because they include only clearly affected and clearly unaffected subjects. Spectrum bias often leads to overestimated test accuracy because intermediate and ambiguous cases are excluded.

When should a diagnostic randomized trial be used instead of a diagnostic accuracy study?

A diagnostic randomized trial should be used when the question is whether using a test improves health outcomes instead of simply whether the test accurately identifies a condition. Diagnostic randomized trials assign subjects to different diagnostic strategies and compare outcomes. These trials provide higher quality evidence but are more complex and expensive to conduct.

Related Articles

• Statistical Power And Sample Size
• Statistical Power And Sample Size
• Statistical Power And Sample Size
• Sample Metadata Standards for Sequencing Projects
• Amplicon Sequencing for Viral Surveillance: Design and Quality Considerations

References and Further Reading

• Research Data Framework. National Institute of Standards and Technology.
• EQUATOR Network. EQUATOR Network.
• Experimental Design Assistant. NC3Rs.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.. BMJ open, 2016.
• Diagnostic Accuracy Studies.. Seminars in nuclear medicine, 2019.
• Observational and interventional study design types, an overview.. Biochemia medica, 2014.
• Study design synopsis: Clinical validation of diagnostic tests.. Equine veterinary journal, 2021.
• Sample size estimation in diagnostic test studies of biomedical informatics.. Journal of biomedical informatics, 2014.
• Multireader Diagnostic Accuracy Imaging Studies: Fundamentals of Design and Analysis.. Radiology, 2022.
• The effect of study design biases on the diagnostic accuracy of magnetic resonance imaging for detecting silicone breast implant ruptures: a meta-analysis.. Plastic and reconstructive surgery, 2011.
• Blinded sample size re-estimation in a comparative diagnostic accuracy study.. BMC medical research methodology, 2022.
• Diagnostic Testing Accuracy: Sensitivity, Specificity, Predictive Values and Likelihood Ratios. 2026.
• [Sensitivity, specificity, predictive values in serological Covid-19 tests].. 2020.
• The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings.. 2015.
• Electrophysiological Markers in Hypertrophic Cardiomyopathy: Enhancing Sudden Cardiac Death Risk Prediction with Index of Cardiac Electrophysiological Balance and Its Corrected Variant.. 2026.
• Diagnostic performance of intraoperative urine dipstick testing during ureteroscopy: association with culture positivity and severe infection.. 2026.
• Automated real-time detection of lung sliding using artificial intelligence: a prospective diagnostic accuracy study.. Chest, 2024.
• Danish study of Non-Invasive testing in Coronary Artery Disease 2 (Dan-NICAD 2): Study design for a controlled study of diagnostic accuracy.. American Heart Journal, 2019.
• THE PREDICTIVE VALUE OF LUNG ULTRASOUND SCORES IN DEVELOPING BRONCHOPULMONARY DYSPLASIA: A PROSPECTIVE MULTICENTER DIAGNOSTIC ACCURACY STUDY.. Chest, 2021.
• Designs and appropriate choices for diagnostic test accuracy study. Chinese Journal of Epidemiology, 2024.
• Comparative diagnostic accuracy study: study design. Chinese Journal of Evidence Based Medicine, 2022.
• The impact of including different study designs in meta-analyses of diagnostic accuracy studies. European Journal of Epidemiology, 2013.
• The choice of study designs of diagnostic accuracy using Borrelia specific IgG and IgM antibodies for the diagnosis of Lyme borreliosis. Clinical Microbiology and Infection, 2025.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.